Drug maker Pfizer Ltd on Thursday said it has appointed Meenakshi Nevatia as managing director for a period of five years with effect from April 3, 2023.
Ms Nevatia succeeds S Sridhar who announced his early retirement in August 2022. Sridhar will be stepping down as managing director with close of business hours on March 31, 2023.
Ms Nevatia has worked with companies such as Mckinsey and Co, Novartis Pharmaceuticals and more recently with Stryker Corporation.
Pfizer Emerging Markets Global President Nick Lagunowich said India is critical to the healthcare ecosystem in the region and globally.
"It is a place where we aspire to bring many more breakthrough therapies and health solutions to patients across the economic segments. We are thrilled to welcome Meenakshi who comes at an important time when we are poised to scale up our contribution to the Indian healthcare industry," he noted.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
Race For Revdis: Good Politics Or Bad Economics?
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50 Pfizer, Merck Pneumonia Shots Approved For Adults Over 50 Pfizer Pauses Gene Therapy Trial For Muscle Disease After Death Naval Personnel Among 13 Killed As Navy Boat Collides With Ferry Near Mumbai World Leaders On Speed-Dial: How Elon Musk Is Causing Geopolitical Tremors Video: Passengers Panic, Scream For Help As Ferry Sinks Off Mumbai Coast Karnataka's Waqf Policy Treating Hindus As "2nd-Grade" Citizens, Says BJP "Allergic" To Ambedkar's Name: Actor Vijay Criticises Amit Shah Amid Row Trump Opposes Deal To Avert Government Shutdown Track Latest News Live on NDTV.com and get news updates from India and around the world.